SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

LYKA LABS

BSE: 500259 22 May 2025
Healthcare
₹ 118.6
Lyka Labs Ltd., specializes in Pharmaceuticals within the Healthcare sector.

LYKA LABS - Share Price & Details

Market Cap
₹421.0
High /Low
177.0 / 90.2
Stock P/E
103.0
Book Value
₹27.7
Dividend Yield
0.0
ROCE
3.53
ROE
₹-5.07
Face Value
10.0
PEG Ratio
15.7
EVEBITDA
₹25.9
Debt
35.2
CMP / FCF
15.9
Debt to equity
₹0.36
NP Ann
-2.62
High price all time
267.0
Piotroski score
₹5.0
Graham Number
26.3
No. Eq. Shares
3.57
Net CF
₹-5.76
Net profit
4.12
Price to book value
4.25
Interest Coverage
₹3.25
Low price all time
8.15
Industry PE
32.1
Reserves
₹63.2
Free Cash Flow
₹-7.46

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic0.700.190.61NA4.1732.1
Triochem Products Ltd.,4.590.88NA3.600
LYKA LABS LTD.337.9526.99329.210.75421.0103.0
BROOKS LABORATORIES LTD.205.439.37205.150.36402227.0
SMS Lifesciences India Ltd829.3862.28828.7720.6039118.6

Peer Comparison Chart


About LYKA LABS

Lyka Labs Ltd.,, with Security Code 500259, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Lyka Labs secures Indian patent for Pregabalin Gel 8%

(10 Apr 2025)
Lyka Labs Limited has announced that it has been granted an Indian Patent for its proprietary product, Pregabalin Gel 8%, with patent...
Read more →

Lyka Labs Ltd secures Indian Patent for Pregabalin Gel 8% - A Novel Topical Solution for Diabetic Neuropathic Pain

(09 Apr 2025)
Lyka Labs Limited has been granted an Indian Patent for its proprietary product, Pregabalin Gel 8%, with patent protection valid through...
Read more →

Lyka Labs gets Indian Patent for diabetic neuropathic pain management gel Pregabalin

(08 Apr 2025)
Mumbai: Lyka Labs Limited has announced that it has been granted an Indian Patent for its proprietary product, Pregabalin Gel 8 percent,...
Read more →

Pharma stock skyrockets 10% after securing patent for Pregabalin Gel to treat neuropathic pain

(08 Apr 2025)
During Tuesday's trading session, the shares of a pharmaceutical company engaged in the development and manufacture of quality finished...
Read more →

Lyka Labs Reports Strong Sales Growth Amid Financial Stability Concerns

(06 Mar 2025)
Lyka Labs has recently adjusted its evaluation following a strong financial performance in Q3 FY24-25, with net sales reaching Rs 74.96 crore and a record...
Read more →

Q3 Results Today: Asian Paints, Tata Power, MobiKwik, Titan, PC Jeweller Among 130 Firms Declaring Earnings

(02 Mar 2025)
As many as 130 companies are scheduled to declare their financial results for the quarter ended Dec. 31, 2024, on Tuesday, Feb. 4.
Read more →